Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta …

AM Aghaei, J Gholami, A Sangchooli… - The Lancet Global …, 2023 - thelancet.com
Background Considerable disease burden is attributed to injecting drug use (IDU). This
regional systematic review and meta-analysis aimed to assess the prevalence of IDU and …

Syphilis infection prevalence in the Middle East and North Africa: a systematic review and meta-analysis

M El-Jamal, B Annan, A Al Tawil, M Hamati… - …, 2024 - thelancet.com
Background Syphilis is a sexually transmitted infection (STI) that can be prevented and
effectively treated; yet it continues to be a cause of morbidity and mortality worldwide. There …

Status of the HIV epidemic in key populations in the Middle East and north Africa: knowns and unknowns

GR Mumtaz, H Chemaitelly, S AlMukdad, A Osman… - The Lancet …, 2022 - thelancet.com
Summary The Middle East and north Africa is one of only two world regions where HIV
incidence is on the rise, with most infections occurring among key populations: people who …

Treatment as prevention for hepatitis C virus in the Middle East and North Africa: a modeling study

HH Ayoub, S Mahmud, H Chemaitelly… - Frontiers in Public …, 2023 - frontiersin.org
Background Direct-acting antivirals opened an opportunity for eliminating hepatitis C virus
(HCV) infection in the Middle East and North Africa (MENA), the region most affected by …

Sexually transmitted infections in the middle east and North Africa: comprehensive systematic review and meta-analysis

D Obeid, F Alsuwairi, R Alnemari, A Al-Qahtani… - BMC infectious …, 2024 - Springer
Background Globally, sexually transmitted infections (STIs) collectively cause 2.3 million
deaths and 1.2 million cases of cancer annually. However, the epidemiology of STIs in the …

Characterizing trends and associations for hepatitis C virus antibody prevalence in the Middle East and North Africa: meta-regression analyses

S Mahmud, H Chemaitelly, AS Alaama, JG Hermez… - Scientific Reports, 2022 - nature.com
This study characterized population-level trends and associations with hepatitis C virus
(HCV) antibody (Ab) prevalence in the Middle East and North Africa (MENA). Data source …

An evolving HIV epidemic in the Middle East and North Africa (MENA) region: A scoping review

A Karbasi, J Fordjuoh, M Abbas, C Iloegbu… - International journal of …, 2023 - mdpi.com
Human immunodeficiency virus (HIV) in the Middle East and North Africa (MENA) region is
severely understudied despite the region's increase in new HIV infections since 2010. A key …

'Secrecy, Trust, Safety': a Multi-stakeholder Situation Assessment of Gendered and Contextual Vulnerabilities and Service Level Responsiveness to the Needs of …

MC Van Hout, H Elsayed, R Elgamil, MA Rabie… - International Journal of …, 2023 - Springer
Women account for one in every three people who use drugs worldwide and tend to
progress to drug use disorders in a shorter time than men. There is limited understanding of …

[HTML][HTML] Sub-genotypes of hepatitis C virus in the Middle East and North Africa: Patterns of distribution and temporal changes

RY Athamneh, R Abudalo, M Sallam, A Alqudah… - Infection, Genetics and …, 2023 - Elsevier
Infection with the hepatitis C virus (HCV) remains a considerable public health concern in
the Middle East and North Africa (MENA). The objectives of this study were to analyze the …

Hepatitis C virus transmission among people who inject drugs in the Middle East and North Africa: mathematical modeling analyses of incidence and intervention …

M Makhoul, GR Mumtaz, HH Ayoub, MS Jamil… - …, 2025 - thelancet.com
Summary Background The Middle East and North Africa (MENA) region is the most affected
by hepatitis C virus (HCV) infection globally. This study aimed to estimate HCV incidence …